The Patent Finder

Molecular Geriatrics Corporation

Also on record
Records under this name other than patents Molecular Geriatrics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Molecular Geriatrics Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,864,062Purified antigen for Alzheimer's disease and methods of obtaining and using same
Lapsed on the fee record
Ended Mar 8, 2013 · USPTO record
Lapsed on the fee recordEnded Mar 8, 2013USPTO record
US 7,173,132Certain substituted 1-aryl-3-piperazine-1′-yl propanones
Lapsed on the fee record
Ended Feb 6, 2011 · USPTO record
Lapsed on the fee recordEnded Feb 6, 2011USPTO record
US 6,306,857Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1'-yl propanones
Lapsed on the fee record
Ended Oct 23, 2009 · USPTO record
Lapsed on the fee recordEnded Oct 23, 2009USPTO record
US 6,214,994Certain substituted 1-aryl-3-piperazin-1'-yl propanones
Lapsed on the fee record
Ended Apr 10, 2009 · USPTO record
Lapsed on the fee recordEnded Apr 10, 2009USPTO record
US 6,228,878Methods for treating or preventing alzheimer's disease using substituted 2-aryl-3-morpholinopropanones
Lapsed on the fee record
Ended May 8, 2005 · USPTO record
Lapsed on the fee recordEnded May 8, 2005USPTO record
US 6,075,026Certain substituted 1-aryl-3-piperazin-1'-yl propanones
Lapsed on the fee record
Ended Jun 13, 2004 · USPTO record
Lapsed on the fee recordEnded Jun 13, 2004USPTO record
US 5,658,909Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
Term ended
Term ended no later than Aug 19, 2017 · Low confidence
Term endedTerm ended no later than Aug 19, 2017Low confidence
US 5,693,804Substituted 1-aryl-3-piperazin-1'-yl propanones
Term ended
Term ended no later than Dec 2, 2017 · Low confidence
Term endedTerm ended no later than Dec 2, 2017Low confidence
US 5,705,501Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's Disease
Term ended
Term ended no later than Jan 6, 2018 · Low confidence
Term endedTerm ended no later than Jan 6, 2018Low confidence
US 5,968,936Methods for treating or preventing Alzheimer's Disease using substituted 1-aryl-3-morpholinopropanones
Term ended
Term ended no later than Oct 19, 2019 · Low confidence
Term endedTerm ended no later than Oct 19, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited